Juan W. Li

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Long-term survival achieved with benmelstobart plus anlotinib in a patient with advanced clear cell renal cell carcinoma: A case report

Long-term survival achieved with benmelstobart plus anlotinib in a patient with advanced clear cell renal cell carcinoma: A case report

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Published: July 23, 2026

Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma.

Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: June 05, 2026

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Journal: Cancer metastasis reviews

Published: April 21, 2026

Features of tumor microenvironment in HER2-positive urothelial carcinoma and its implications for immunotherapy resistance.

Features of tumor microenvironment in HER2-positive urothelial carcinoma and its implications for immunotherapy resistance.

Journal: BMC cancer

Published: April 11, 2026

Challenges in Interpreting MELATORCH Trial Outcomes-Reply.

Challenges in Interpreting MELATORCH Trial Outcomes-Reply.

Journal: JAMA oncology

Published: April 09, 2026

An integrative epigenomic and single-cell framework identifies a prognostic DNA methylation risk score and ZNF638 silencing in urothelial carcinoma.

An integrative epigenomic and single-cell framework identifies a prognostic DNA methylation risk score and ZNF638 silencing in urothelial carcinoma.

Journal: Journal of translational medicine

Published: January 22, 2026

NQO1-Mediated Anoikis Resistance and Immune Evasion Define a High-Risk Multi-Omic Subtype for Precision Management of T1 High-Grade Bladder Cancer.

NQO1-Mediated Anoikis Resistance and Immune Evasion Define a High-Risk Multi-Omic Subtype for Precision Management of T1 High-Grade Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 19, 2025

Toripalimab in patients with previously treated advanced upper tract urothelial carcinoma: a subgroup analysis of the phase II POLARIS-03 trial.

Toripalimab in patients with previously treated advanced upper tract urothelial carcinoma: a subgroup analysis of the phase II POLARIS-03 trial.

Journal: The oncologist

Published: October 07, 2025

MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma.

MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 31, 2025

First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.

First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: March 18, 2025

Single-Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling.

Single-Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 16, 2025

Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study.

Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study.

Journal: Med (New York, N.Y.)

Published: September 02, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026